Establishing the Glycaemic Index of Vegetable Smoothies (VEG-GI)

July 22, 2026 updated by: Emma Greatorex Brooks, University of Bath

Study to Establish Glycaemic Response to the Ingestion of Vegetable Smoothies Expressed as Glycaemic Index Following Best Practice Guidelines

Glycaemic responses to carbohydrates ingested as fruit and vegetables may vary depending on factors inherent to the fruit or vegetable, and on the type of sugar. The aim of this project is to investigate the glycaemic responses to two new fruit and vegetable smoothies, and to establish the glycaemic index for each product relative to a glucose reference. Participants will undertake 4 postprandial tests with 2 different test drinks following best practice guidelines for glycaemic index testing. The test drinks (GREEN and RED) will be matched for carbohydrate to the glucose reference (CONTROL) which will be sampled two times. Fingerstick capillary blood sampling will measure glucose concentrations. These data will provide insight into how differing formulations can alter the glycaemic responses to fruit and vegetable drinks.

Study Overview

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bath, United Kingdom, BA2 7AY
        • Department for Health, University of Bath

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age: 18-65 years
  • Body mass index 18-30 kg/m2

Exclusion Criteria:

  • diagnosis of any form of diabetes
  • intolerances or allergies to any of the study procedures (e.g. fructose/inulin intolerance)
  • Fructose malabsorption
  • Inborn errors of fructose metabolism (e.g. fructokinase deficiency, aldolase B deficiency, fructose-1,6-bisphosphatase deficiency)
  • pregnant or lactating
  • any condition that could introduce bias to the study (e.g. diagnoses of lipid disorders, including cardiovascular disease, or therapies that alter lipid or glucose metabolism, such as statins or niacin).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: CONTROL
50 g glucose (55 g dextrose powder accounting for hydration) plus 519 mL water
Commercially available fruit and vegetable smoothie
Active Comparator: REPLICATE CONTROL
50 g glucose (55 g dextrose powder accounting for hydration) plus 519 mL water
Commercially available fruit and vegetable smoothie
Experimental: RED
500 mL of commercially available "Red Goodness" providing 50 g of carbohydrate [apple (47%), banana, chayote (8%), beetroot (7%), carrot (5%), cucumber (5%), cherry (3%), spinach (2%), mandarin, lemon, apple water, beetroot extract]. Plus 19 mL water to standardise volume
Commercially available fruit and vegetable smoothie
Experimental: GREEN
519 mL of commercially available "Green Goodness" smoothie providing 50 g carbohydrate [apples (46%), banana, courgette (10%), chayote (8%), guava, cucumber (5%), lemon (3%), spinach (2%), mandarin, apple water spirulina extract, turmeric extract, mint extract].
Commercially available fruit and vegetable smoothie

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycaemic indices for 2 test drinks measured using capillary blood samples
Time Frame: 120 minutes
Glycaemic indices [2-hour incremental area under the glucose curve (mmol/L-1x120 minutes) for each of the 2 test drinks relative to mean value of control conditions (CONTROL, REPLICATE CONTROL), expressed as a percentage] in capillary blood samples
120 minutes

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparisons between conditions in glucose concentration in capillary samples
Time Frame: 120 minutes
Comparison of blood glucose concentration 2-hour incremental area under the curve (iAUC) min.mmol/L between test conditions
120 minutes
Comparisons between conditions in glucose concentration in capillary samples
Time Frame: 120 minutes
Comparison of postprandial peak concentration mmol/L of blood glucose between test conditions (Cmax)
120 minutes
Comparisons between conditions in glucose concentration in capillary samples
Time Frame: 120 minutes
Comparison of time to peak blood glucose concentration in minutes (Tmax) between test conditions
120 minutes
Comparisons between conditions in glucose concentration in capillary samples
Time Frame: 120 minutes
Comparison of blood glucose concentration mmol/L at 2 hours between test conditions
120 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 22, 2025

Primary Completion (Actual)

December 15, 2025

Study Completion (Actual)

December 15, 2025

Study Registration Dates

First Submitted

July 22, 2026

First Submitted That Met QC Criteria

July 22, 2026

First Posted (Actual)

July 27, 2026

Study Record Updates

Last Update Posted (Actual)

July 27, 2026

Last Update Submitted That Met QC Criteria

July 22, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 10814-13276

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified data will be made available open access on the University of Bath Research Data Archive (RDA) at the point of publication in a peer-reviewed journal

IPD Sharing Time Frame

These will become available at the point of publication permanently

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glycaemic Index

Clinical Trials on Vegetable Smoothie

Subscribe